4-butyrolactone has been researched along with Alzheimer Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Chen, YS; Du, JR; He, Q; Kuang, X; Li, LJ; Li, YJ; Liu, K; Wang, LF; Wang, Y; Zhang, MX | 1 |
| Chen, YS; Du, JR; Kuang, X; Wang, J; Wang, YN | 1 |
| Caron, G; Ermondi, G; Fall, Y; Gándara, Z; Gerbaldo, M; Gómez, G; Martínez, A; Pérez, DI; Pérez, M; Pintos, IG | 1 |
| Bi, J; Miao, J; Wang, P; Wei, L; Xie, Z; Xu, S; Yang, H; Yang, S; Zhao, B; Zhao, C | 1 |
| Du, JR; Yu, Y; Zhang, MX | 1 |
5 other study(ies) available for 4-butyrolactone and Alzheimer Disease
| Article | Year |
|---|---|
Klotho upregulation contributes to the neuroprotection of ligustilide in an Alzheimer's disease mouse model.
Topics: 4-Butyrolactone; Aging; Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Cells, Cultured; Disease Models, Animal; Forkhead Box Protein O1; Forkhead Transcription Factors; Gene Expression Regulation, Developmental; Glucuronidase; Insulin-Like Growth Factor I; Klotho Proteins; Male; Memory Disorders; Mice; Mice, Inbred Strains; Molecular Targeted Therapy; Neuroprotective Agents; Oxidative Stress; Peptide Fragments; Phosphorylation; Signal Transduction; tau Proteins; Up-Regulation | 2014 |
Protective effect of Z-ligustilide against amyloid beta-induced neurotoxicity is associated with decreased pro-inflammatory markers in rat brains.
Topics: 4-Butyrolactone; Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Disease Models, Animal; Humans; Inflammation Mediators; Injections, Intraventricular; Male; Maze Learning; Neuroprotective Agents; NF-kappa B; Rats; Rats, Wistar; Signal Transduction; Tumor Necrosis Factor-alpha | 2009 |
An application of two MIFs-based tools (Volsurf+ and Pentacle) to binary QSAR: the case of a palinurin-related data set of non-ATP competitive glycogen synthase kinase 3β (GSK-3β) inhibitors.
Topics: 4-Butyrolactone; Alzheimer Disease; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Models, Biological; Models, Molecular; Quantitative Structure-Activity Relationship; Software; Stereoisomerism | 2011 |
A butyrolactone derivative 3BDO alleviates memory deficits and reduces amyloid-β deposition in an AβPP/PS1 transgenic mouse model.
Topics: 4-Butyrolactone; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Autophagy; Brain; Disease Models, Animal; Insulysin; Maze Learning; Memory Disorders; Mice; Mice, Transgenic; Neprilysin; Presenilin-1; Signal Transduction | 2012 |
[Protective effects of Z-ligustilide against cytotoxicity induced by Abeta25-35 in neuron cells].
Topics: 4-Butyrolactone; Alzheimer Disease; Amyloid beta-Peptides; Apoptosis; Cell Line, Tumor; Humans; Neuroblastoma; Neurons; Neuroprotective Agents; Peptide Fragments | 2012 |